MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions for cardiometabolic and orphan lung ...

There could be a test to screen for type 1 diabetes after new research by scientists found early markers.

Adolescents and young adults with type 1 diabetes who reported receiving help with managing their disease may have better glycemic outcomes as they transition from pediatric to adult care, researchers ...

Please provide your email address to receive an email when new articles are posted on . Adults are 1.64 times more likely to develop type 1 diabetes if their father has type 1 diabetes rather than ...

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) suggests that living in a rural environment ...

A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much ...

One challenge of using cell therapy to treat type 1 diabetes is that this approach requires chronic suppression of the immune system to prevent rejection of donor cells. A Vertex Pharmaceuticals ...

Tirzepatide produced significant weight loss, reduced insulin requirements, and improved glucose control without increasing hypoglycemia when used off-label in adults with type 1 diabetes (T1D), new ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...

Danbury, Connecticut Tuesday, February 10, 2026, 18:00 Hrs [IST] ...